Parnax Lab Ltd

Parnax Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Parnax Lab Ltd

₹ 100 -1.96%
04 Jul 4:01 p.m.
naxparlab.com BSE: 506128
About

Incorporated in 1985, Parnax Lab Ltd manufactures and exports Pharmaceutical Formulations[1]

Key Points

Business Overview:[1][2]
PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located
at Silvassa.

Website BSE
  • Market Cap ₹ 115 Cr.
  • Current Price ₹ 100
  • High / Low ₹ 168 / 64.2
  • Stock P/E 12.0
  • Book Value ₹ 62.3
  • Dividend Yield 0.00 %
  • ROCE 12.9 %
  • ROE 14.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 23.8% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
20.48 28.69 35.75 50.68 47.91 36.74 43.14 46.82 40.91 48.74 42.61 50.99 46.37
20.80 25.33 30.20 43.57 40.90 31.43 37.58 39.44 36.18 42.24 37.32 45.02 40.58
Operating Profit -0.32 3.36 5.55 7.11 7.01 5.31 5.56 7.38 4.73 6.50 5.29 5.97 5.79
OPM % -1.56% 11.71% 15.52% 14.03% 14.63% 14.45% 12.89% 15.76% 11.56% 13.34% 12.41% 11.71% 12.49%
0.09 0.04 0.07 0.02 0.21 0.12 0.30 0.08 0.27 0.24 0.22 0.10 0.25
Interest 1.27 1.17 1.44 1.25 1.37 1.26 1.20 1.30 1.18 1.16 1.43 1.35 1.41
Depreciation 1.33 1.26 1.30 1.31 2.00 1.66 1.55 1.74 1.59 1.60 1.74 1.78 1.84
Profit before tax -2.83 0.97 2.88 4.57 3.85 2.51 3.11 4.42 2.23 3.98 2.34 2.94 2.79
Tax % -9.89% 0.00% 0.00% 0.00% 104.16% 23.11% 32.48% 28.51% 35.43% 16.33% 20.09% 25.85% 19.35%
-3.11 0.97 2.88 4.56 -0.15 1.93 2.10 3.16 1.44 3.33 1.87 2.18 2.24
EPS in Rs -3.64 1.14 3.37 5.35 -0.15 1.97 1.83 2.74 1.25 2.89 1.63 1.90 1.95
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
58 70 103 71 95 106 109 95 90 163 168 189
50 62 91 61 82 95 99 89 80 140 145 165
Operating Profit 7 8 12 10 13 10 10 6 10 23 23 24
OPM % 13% 12% 12% 14% 14% 10% 9% 7% 11% 14% 14% 12%
1 1 1 1 0 1 2 1 0 0 1 1
Interest 4 4 4 4 5 4 4 5 5 5 5 5
Depreciation 2 2 3 3 4 4 4 4 5 6 7 7
Profit before tax 3 3 5 3 5 3 5 -2 -0 12 12 12
Tax % 35% 27% 22% 28% 22% 65% 28% -48% -350% 33% 30% 20%
2 2 4 3 4 1 3 -3 -0 8 9 10
EPS in Rs 2.01 2.93 5.01 2.95 4.33 1.23 3.88 -3.42 -0.42 8.40 7.51 8.37
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 12%
3 Years: 28%
TTM: 13%
Compounded Profit Growth
10 Years: 14%
5 Years: 24%
3 Years: 204%
TTM: 12%
Stock Price CAGR
10 Years: 6%
5 Years: 32%
3 Years: 57%
1 Year: 60%
Return on Equity
10 Years: 10%
5 Years: 10%
3 Years: 16%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 8 8 8 8 8 8 8 8 10 11 11
Reserves 10 12 17 19 23 24 27 24 24 37 51 60
27 33 41 42 39 37 42 51 59 69 55 81
15 29 17 10 15 18 17 23 15 38 28 37
Total Liabilities 60 83 83 79 86 87 95 107 106 153 145 189
33 36 36 38 47 44 51 58 60 72 77 109
CWIP 0 1 1 2 0 0 0 3 5 3 2 1
Investments 1 1 1 1 0 0 0 0 0 0 0 0
27 46 45 38 38 43 43 46 41 78 66 79
Total Assets 60 83 83 79 86 87 95 107 106 153 145 189

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
6 -0 -0 3 16 13 9 9 6 9 21 16
-1 -6 -4 -6 -10 -5 -11 -13 -7 -16 -10 -32
-3 6 6 1 -5 -7 1 5 0 12 -14 15
Net Cash Flow 1 0 1 -2 0 1 -1 0 -0 4 -3 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 87 130 84 100 72 65 64 88 68 85 61 63
Inventory Days 72 143 38 64 50 45 52 76 80 73 79 106
Days Payable 104 203 51 30 48 45 44 74 46 81 53 79
Cash Conversion Cycle 55 71 71 134 74 64 72 90 102 77 86 90
Working Capital Days 43 75 59 74 34 44 53 77 103 73 67 75
ROCE % 14% 15% 16% 11% 14% 11% 12% 3% 6% 17% 15%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
62.59% 62.59% 62.59% 67.58% 67.58% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30%
37.41% 37.41% 37.41% 32.42% 32.42% 27.71% 27.71% 27.70% 27.69% 27.69% 27.70% 27.70%
No. of Shareholders 2,2072,1392,2592,4032,6053,0963,0703,0603,2213,5433,5364,496

Documents

Announcements

Annual reports

Credit ratings